EPO-TBI trial was published in The Lancet today Whilst there was a small reduction in mortaility this was offset by more severely disabled survivors with no difference in a dichotomised outcome. EPO-TBI failed to show any benefit and there was no difference in transfusion requirements between the treatment group and control group. image image